Rositsa Koleva-Kolarova

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 19

Top Topics

Polycyclic Aromatic Hydrocarbons

Metastatic Breast Cancer

Top Venues

Journal of the American Heart Association

Personalized medicine

PharmacoEconomics

Applied health economics and health policy

This page only lists publications with an associated author ORCID identifier.

Publications

Ka Keat Lim, Rositsa Koleva-Kolarova, Hanin Farhana Kamaruzaman, Ahmad Amir Kamil, Phillip J Chowienczyk, Charles D A Wolfe, Julia Fox-Rushby
Genetic-Guided Pharmacotherapy for Coronary Artery Disease: A Systematic and Critical Review of Economic Evaluations. Journal of the American Heart Association 13 (5) (2024)
Ka Keat Lim, Rositsa Koleva-Kolarova, Hanin Farhana Kamaruzaman, Ahmad Amir Kamil, Phillip J Chowienczyk, Charles D A Wolfe, Julia Fox-Rushby
Genetic-Guided Pharmacotherapy for Coronary Artery Disease: A Systematic and Critical Review of Economic Evaluations. Journal of the American Heart Association 13 (5) (2024)
Ka Keat Lim, Rositsa Koleva-Kolarova, Hanin Farhana Kamaruzaman, Ahmad Amir Kamil, Phillip J Chowienczyk, Charles D A Wolfe, Julia Fox-Rushby
Genetic-Guided Pharmacotherapy for Coronary Artery Disease: A Systematic and Critical Review of Economic Evaluations. Journal of the American Heart Association 13 (5) (2024)
Ka Keat Lim, Rositsa Koleva-Kolarova, Hanin Farhana Kamaruzaman, Ahmad Amir Kamil, Phillip J Chowienczyk, Charles D A Wolfe, Julia Fox-Rushby
Genetic-Guided Pharmacotherapy for Coronary Artery Disease: A Systematic and Critical Review of Economic Evaluations. Journal of the American Heart Association 13 (5) (2024)
Ka Keat Lim, Rositsa Koleva-Kolarova, Hanin Farhana Kamaruzaman, Ahmad Amir Kamil, Phillip J Chowienczyk, Charles D A Wolfe, Julia Fox-Rushby
Genetic-Guided Pharmacotherapy for Coronary Artery Disease: A Systematic and Critical Review of Economic Evaluations. Journal of the American Heart Association (2024)
Ka Keat Lim, Rositsa Koleva-Kolarova, Hanin Farhana Kamaruzaman, Ahmad Amir Kamil, Phillip J Chowienczyk, Charles D A Wolfe, Julia Fox-Rushby
Genetic-Guided Pharmacotherapy for Coronary Artery Disease: A Systematic and Critical Review of Economic Evaluations. Journal of the American Heart Association 13 (5) (2024)
Ka Keat Lim, Rositsa Koleva-Kolarova, Hanin Farhana Kamaruzaman, Ahmad Amir Kamil, Phillip J Chowienczyk, Charles D A Wolfe, Julia Fox-Rushby
Genetic-Guided Pharmacotherapy for Coronary Artery Disease: A Systematic and Critical Review of Economic Evaluations. Journal of the American Heart Association 13 (5) (2024)
Ka Keat Lim, Rositsa Koleva-Kolarova, Hanin Farhana Kamaruzaman, Ahmad Amir Kamil, Phillip J Chowienczyk, Charles D A Wolfe, Julia Fox-Rushby
Genetic-Guided Pharmacotherapy for Coronary Artery Disease: A Systematic and Critical Review of Economic Evaluations. Journal of the American Heart Association 13 (5) (2024)
Ka Keat Lim, Rositsa Koleva-Kolarova, Hanin Farhana Kamaruzaman, Ahmad Amir Kamil, Phillip J Chowienczyk, Charles D A Wolfe, Julia Fox-Rushby
Genetic-Guided Pharmacotherapy for Coronary Artery Disease: A Systematic and Critical Review of Economic Evaluations. Journal of the American Heart Association 13 (5) (2024)
Rositsa Koleva-Kolarova, Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, Maureen P M H Rutten-van Mölken, László Szilberhorn, Tamás Zelei, Balázs Nagy, Sarah Wordsworth, Apostolos Tsiachristas
Cost-effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK. Personalized medicine (2023)
László Szilberhorn, Tamás Zelei, Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, Maureen P M H Rutten-van Mölken, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, Balázs Nagy
Cost-effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries. Personalized medicine (2023)
Gábor Kovács, Dávid Nagy, László Szilberhorn, Tamás Zelei, Zsolt Gaál, Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, Maureen P M H Rutten-van Mölken, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, Balázs Nagy
Cost-effectiveness of genetic-based screening strategies for maturity-onset diabetes of the young. Personalized medicine (2023)
Balázs Nagy, Tamás Zelei, Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, Maureen P M H Rutten-van Mölken, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, László Szilberhorn
Lessons learned from the application of the HEcoPerMed guidance to three modeling case studies. Personalized medicine (2023)
Rositsa Koleva-Kolarova, László Szilberhorn, Tamás Zelei, Heleen Vellekoop, Balázs Nagy, Simone A Huygens, Matthijs M Versteegh, Maureen P M H Rutten-van Mölken, Sarah Wordsworth, Apostolos Tsiachristas
Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation. Personalized medicine (2023)
Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, László Szilberhorn, Tamás Zelei, Balázs Nagy, Rositsa Koleva-Kolarova, Sarah Wordsworth, Maureen P M H Rutten-van Mölken, null null
Cost-effectiveness of alternative NTRK testing strategies in cancer patients followed by histology-independent therapy with entrectinib: an analysis of three European countries. Personalized medicine (2023)
Rositsa Koleva-Kolarova, Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, Maureen P M H Rutten-van Mölken, László Szilberhorn, Tamás Zelei, Balázs Nagy, Sarah Wordsworth, Apostolos Tsiachristas
Budget impact and transferability of cost-effectiveness of DPYD testing in metastatic breast cancer in three health systems. Personalized medicine (2023)
Rositsa Koleva-Kolarova, James Buchanan, Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, Maureen Rutten-van Mölken, László Szilberhorn, Tamás Zelei, Balázs Nagy, Sarah Wordsworth, Apostolos Tsiachristas, null null
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options. Applied health economics and health policy 20 (4) (2022)
Ka Keat Lim, Rositsa Koleva-Kolarova, Julia Fox-Rushby
A Comparison of the Content and Consistency of Methodological Quality and Transferability Checklists for Reviewing Model-Based Economic Evaluations. PharmacoEconomics 40 (10) (2022)
Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, László Szilberhorn, Tamás Zelei, Balázs Nagy, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, Maureen P M H Rutten-van Mölken, null null
Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine. PharmacoEconomics 39 (7) (2021)